Wealth Enhancement Advisory Services’s AbbVie ABBV Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$489K	Buy	+2,400	New	+$516K	﹤0.01%	2708
2024 Q4	–	Sell	-13,300	Closed	-$51.9K	–	2945
2024 Q3	$51.9K	Buy	13,300 +12,900	+3,225%	+$2.41M	﹤0.01%	2617
2024 Q2	$3.74K	Sell	400 -11,600	-97%	-$1.92M	﹤0.01%	2556
2024 Q1	$1.68K	Sell	12,000 -1,300	-10%	-$224K	﹤0.01%	2462
2023 Q4	$18.5K	Hold	13,300	–	–	﹤0.01%	2260
2023 Q3	$45.9K	Buy	+13,300	New	+$1.95M	﹤0.01%	2163

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Wealth Enhancement Advisory Services's ABBV Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its AbbVie (ABBV) stake by 6.7% in Q2 2026, buying an estimated $7.75M and bringing the position to 576,543 shares worth $117M. The position accounts for 0.2% of the portfolio, ranked #95.

Wealth Enhancement Advisory Services first reported a position in ABBV in Q4 2017 and has held it in 31 quarters since. The position peaked at $143M in Q4 2025. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wealth Enhancement Advisory Services held 576,543 shares of AbbVie worth $117M as of Q2 2026.
Wealth Enhancement Advisory Services bought 36,002 AbbVie shares in Q2 2026, an estimated $7.75M.
AbbVie made up 0.2% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #95 holding.
Wealth Enhancement Advisory Services first reported a position in AbbVie in Q4 2017 and has held it in 31 quarters since.
Wealth Enhancement Advisory Services's AbbVie position peaked at $143M in Q4 2025.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.